Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FA15U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,109
Award facts
- Contract value 100% obligated
- $21,108.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $21,108.85. This firm fixed-price delivery order, with an ultimate completion date of October 23, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026 that supplies medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly fulfills federal medical procurement requirements through its substantial contract portfolio with the Defense Logistics Agency. As a critical vendor for military and veteran healthcare systems, the company supplies an extensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. The delivery of Gemtesa—a urological medication—exemplifies the company's versatility in meeting diverse federal medical supply needs through competitively awarded delivery orders under its prime IDC vehicle with DLA.
Quick answers
Who was awarded contract SPE2DB26FA15U?
SPE2DB26FA15U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FA15U worth?
The government has obligated $21,109 on SPE2DB26FA15U.
Is contract SPE2DB26FA15U an order under another contract?
Yes. SPE2DB26FA15U is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA15U competed?
The extent of competition for SPE2DB26FA15U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award